ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer
Colorectal Disease · 2026-05 · 28 (5)
DOI: 10.1111/codi.70495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, online erschienen am 22.05.2026. Verfasst von J D Mason und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK. Hauptthemen laut MEDLINE: Colectomy, Colonic Neoplasms, Mesocolon. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Complete mesocolic excision (CME) has been proposed as a refinement of oncological surgery for right‐sided colon cancer, aiming to improve specimen quality, lymph node yield and oncological outcomes. However, its routine adoption remains controversial due to uncertainty regarding oncological benefit and concerns relating to technical complexity, training and service delivery. This position statement from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) examines the contemporary evidence surrounding CME and its role within modern management of right‐sided colon cancer.
Methods
This position statement was produced by the authors who represent a range of views on CME surgery. It synthesises contemporary evidence from large cohort studies, recent randomised control trials and international guidelines to evaluate the role of CME compared with standard high‐quality right hemicolectomy.
Results
CME is consistently associated with higher lymph node yields and improved specimen metrics, but studies demonstrating a definitive survival advantage remain limited. Randomised evidence does not support routine CME for all patients, although potential benefit exists in selected high‐risk groups. Recent evidence suggests that surgical plane quality, rather than the extent of lymphadenectomy, may be the principal determinant of oncological outcomes. CME is technically demanding and may carry increased procedural risks, particularly related to central vascular dissection, although these may be mitigated through structured training and optimised perioperative planning.
Conclusion
Routine use of CME for all right‐sided colon cancers is not supported by current evidence. Standard high‐quality right hemicolectomy should remain the default approach for most patients. Selective use of CME may be appropriate in physiologically fit patients with high‐risk or anatomically complex disease, delivered within experienced units with appropriate training, audit and quality assurance frameworks. Future progress will depend on standardisation of surgical technique, objective assessment of specimen quality and biologically tailored treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Churchill Hospital, Oxford, UK.
- Department of Colorectal Surgery, Portsmouth Hospitals University NHS Trust, Queen Alexandra Hospital, Portsmouth, UK.
- Faculty of Science and Health, University of Portsmouth, Portsmouth, UK.
- Department of Colorectal Surgery, Liverpool University Hospitals NHS Foundation Trust, Royal Liverpool University Hospital, Liverpool, UK.
- Department of Colorectal Surgery, Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
- Department of Colorectal Surgery, Royal Surrey NHS Foundation Trust, Royal Surrey County Hospital, Guildford, UK.
ORCID-Profile: J D Mason, C Cunningham
Zitieren
APA
Mason, J. D., Khan, J. S., Ahmed, S., Coyne, P., Read, J. W., Bundred, J., Buczacki, S. J. A., Harikrishnan, A., Cunningham, C., & Association of Coloproctology of Great Britain & Ireland (ACPGBI) (2026). ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer. Colorectal Disease, 28(5). https://doi.org/10.1111/codi.70495
Vancouver
Mason JD, Khan JS, Ahmed S, Coyne P, Read JW, Bundred J, et al. ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer. Colorectal Disease. 2026;28(5). doi:10.1111/codi.70495
BibTeX
@article{Mason2026,
author = {Mason, J D and Khan, J S and Ahmed, S and Coyne, P and Read, J W and Bundred, J and Buczacki, S J A and Harikrishnan, A and Cunningham, C and Association of Coloproctology of Great Britain & Ireland (ACPGBI), Association of Coloproctology of Great Britain & Ireland (ACPGBI)},
title = {ACPGBI position statement on the role of standard high‐quality right hemicolectomy and complete mesocolic excision in right‐sided colon cancer},
journal = {Colorectal Disease},
year = {2026},
volume = {28},
number = {5},
doi = {10.1111/codi.70495}
}
EUVIMED